Context Therapeutics Correlations

CNTX Stock

USD 0.84 0 0.12%

The current 90-days correlation between Context Therapeutics and Acumen Pharmaceuticals is 0.31 (i.e., Weak diversification). The correlation of Context Therapeutics is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak. If the correlation is 0, the equities are not correlated; they are entirely random.

Context Therapeutics Correlation With Market

Average diversification

The correlation between Context Therapeutics and DJI is 0.18 (i.e., Average diversification) for selected investment horizon. Overlapping area represents the amount of risk that can be diversified away by holding Context Therapeutics and DJI in the same portfolio, assuming nothing else is changed.

Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Context Therapeutics. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in estimate.

For more information on how to buy Context Stock please use our How to Invest in Context Therapeutics guide.

Moving together with Context Stock

0.86	EXAS	EXACT Sciences	Pair Corr
0.92	FATE	Fate Therapeutics	Pair Corr
0.86	NVO	Novo Nordisk AS	Pair Corr
0.72	ILMN	Illumina	Pair Corr
0.81	INZY	Inozyme Pharma Earnings Call This Week	Pair Corr
0.85	KURA	Kura Oncology	Pair Corr
0.88	NTLA	Intellia Therapeutics	Pair Corr
0.88	REGN	Regeneron Pharmaceuticals	Pair Corr
0.95	ABOS	Acumen Pharmaceuticals	Pair Corr
0.97	ADTX	Aditxt Inc	Pair Corr
0.86	STRO	Sutro Biopharma	Pair Corr
0.9	TCRX	Tscan Therapeutics	Pair Corr
0.91	TERN	Terns Pharmaceuticals Earnings Call This Week	Pair Corr

Moving against Context Stock

0.73	OPT	Opthea	Pair Corr
0.61	GANX	Gain Therapeutics	Pair Corr
0.6	LTRN	Lantern Pharma	Pair Corr
0.58	PFE	Pfizer Inc	Pair Corr
0.55	FENC	Fennec Pharmaceuticals	Pair Corr
0.51	CUE	Cue Biopharma	Pair Corr
0.49	VERV	Verve Therapeutics	Pair Corr
0.42	TMO	Thermo Fisher Scientific	Pair Corr
0.64	PHGE	Biomx Inc	Pair Corr
0.55	DBVT	DBV Technologies Earnings Call Today	Pair Corr
0.49	CGTX	Cognition Therapeutics	Pair Corr
0.33	CPRX	Catalyst Pharmaceuticals	Pair Corr

Related Correlations Analysis

	TERN	AMLX	ABOS	INZY	XFOR	SPRO	BOLT	CHRS	GRCL	NLTX
TERN		0.79	0.91	0.92	0.31	0.91	0.71	0.84	0.0	0.0	TERN
AMLX	0.79		0.91	0.68	-0.15	0.84	0.81	0.47	0.0	0.0	AMLX
ABOS	0.91	0.91		0.81	0.08	0.94	0.86	0.72	0.0	0.0	ABOS
INZY	0.92	0.68	0.81		0.45	0.86	0.67	0.79	0.0	0.0	INZY
XFOR	0.31	-0.15	0.08	0.45		0.16	0.03	0.43	0.0	0.0	XFOR
SPRO	0.91	0.84	0.94	0.86	0.16		0.87	0.78	0.0	0.0	SPRO
BOLT	0.71	0.81	0.86	0.67	0.03	0.87		0.57	0.0	0.0	BOLT
CHRS	0.84	0.47	0.72	0.79	0.43	0.78	0.57		0.0	0.0	CHRS
GRCL	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0		0.0	GRCL
NLTX	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0		NLTX
	TERN	AMLX	ABOS	INZY	XFOR	SPRO	BOLT	CHRS	GRCL	NLTX

Click cells to compare fundamentals

Check Volatility

Backtest Portfolio

Please upgrade your account to get full access to Macroaxis premium features

Correlation Matchups

Over a given time period, the two securities move together when the Correlation Coefficient is positive. Conversely, the two assets move in opposite directions when the Correlation Coefficient is negative. Determining your positions' relationship to each other is valuable for analyzing and projecting your portfolio's future expected return and risk.

High positive correlations

SPRO	+ 0.94	ABOS
INZY	+ 0.92	TERN
ABOS	+ 0.91	TERN
SPRO	+ 0.91	TERN
ABOS	+ 0.91	AMLX
BOLT	+ 0.87	SPRO

High negative correlations

XFOR	- 0.15	AMLX
NLTX	- 0.0	GRCL
NLTX	- 0.0	CHRS
GRCL	- 0.0	CHRS
NLTX	- 0.0	BOLT
GRCL	- 0.0	BOLT

Risk-Adjusted Indicators

There is a big difference between Context Stock performing well and Context Therapeutics Company doing well as a business compared to the competition. There are so many exceptions to the norm that investors cannot definitively determine what's good or bad unless they analyze Context Therapeutics' multiple risk-adjusted performance indicators across the competitive landscape. These indicators are quantitative in nature and help investors forecast volatility and risk-adjusted expected returns across various positions.

	Mean Deviation	Jensen Alpha	Sortino Ratio	Treynor Ratio	Semi Deviation	Expected Shortfall	Potential Upside	Value @Risk	Maximum Drawdown
TERN	3.13	(0.58)	0.00	(0.62)	0.00	0.00	5.17	(6.98)	26.61
AMLX	3.42	(0.78)	0.00	(0.81)	0.00	0.00	5.32	(8.54)	16.76
ABOS	2.99	(0.84)	0.00	(0.79)	0.00	0.00	6.57	(6.78)	19.77
INZY	4.04	(1.00)	0.00	(0.94)	0.00	0.00	7.72	(9.17)	38.13
XFOR	7.50	0.70	0.09	(1.29)	7.39	(11.07)	26.42	(13.51)	68.45
SPRO	2.48	(0.50)	0.00	(0.96)	0.00	0.00	4.85	(6.25)	21.98
BOLT	2.61	(0.40)	0.00	(1.68)	0.00	0.00	5.00	(6.45)	17.46
CHRS	4.73	0.07	0.00	(0.02)	0.00	0.00	12.30	(9.09)	37.41
GRCL	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
NLTX	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00

Context Therapeutics Corporate Management

Alex Esq	Chief Secretary	Profile
Martin Lehr	President, CoFounder	Profile
Christopher MBA	Senior Operations	Profile
Tarek MD	Chief Officer	Profile
Elizabeth CPA	Controller	Profile
Jennifer MinaiAzary	CFO Treasurer	Profile
Claudio MD	Chief Officer	Profile

Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions

Feedback Blog

Made with optimal in San Francisco

2024 Macroaxis LLC